DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE

According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosph...

Full description

Saved in:
Bibliographic Details
Main Authors HORI, NOBUYUKI, HORIBA, NAOSHI, HARADA, TAKEO, KASWIWAGI, HIROTAKA, MURATA, YOSHIHISA, ONO, YOSHIYUKI, OHTOMO, SHUICHI, OKAMOTO, NAOKI, TACHIBANA, KAZUTAKA, IDE, MITSUAKI, MIZUGUCHI, EISAKU, ICHIDA, YASUHIRO, OHTAKE, YOSHIHITO, KIMBARA, ATSUSHI, NOMURA, KENICHI, TANAKA, SHOTA
Format Patent
LanguageEnglish
Spanish
Published 10.02.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure. La presente invención proporciona un derivado de dihidropiridazin-3,5-diona o una sal del mismo, o un solvato del compuesto o la sal, un fármaco farmacéutico, una composición farmacéutica, un inhibidor del transportador de fosfato dependiente de sodio y un agente de prevención y/o terapéutico para la hiperfosfatemia, hiperparatiroidismo secundario, e insuficiencia renal crónica, que comprende el compuesto como un ingrediente activo, y un método para la prevención y/o tratamiento.
Bibliography:Application Number: MX20150012537